Biopharmconsortium Blog

Expert commentary from Haberman Associates biotechnology and pharmaceutical consulting.

Monthly Archives: May 2013

Haberman Associates has a new website!

Tweet Haberman Associates now has a new website, which is available at http://biopharmconsortium.com. Our new site has an attractive, up-to-date look and feel, and also contains updated news and other updated content. We have also fully integrated our Biopharmconsortium Blog into our new site. Our blog resides at http://biopharmconsortium.com/blog. There has been a hiatus in…

New findings on mechanism of activation of sirtuins may vindicate Sirtris founders

TweetThe Biopharmconsortium Blog has from time to time been following novel developments in anti-aging medicine, including attempts to develop activators of sirtuins. However, we have not had an article on sirtuins since December 1, 2010. At that time, we reported on the discontinuation by GlaxoSmithKline (GSK) of its lead sirtuin activator, SRT501, a proprietary formulation…